EN PL

FDA: Testicular Toxicity: Evaluation During Drug Development

16.07.2015
The purpose of this guidance is to assist sponsors who are developing drug products that may have potential adverse effects on the testes, which we refer to as testicular toxicity, based on findings in nonclinical studies.